Latest / Stock Movers / KB Home Drops, Sarepta Jumps, ARM Gains on Plans to Sell Its Own Chips
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The.
- 0:08Speaker 2: Stock Movers Report, your roundup of companies making moves in
- 0:12Speaker 2: the stock market, harnessing the power of Bloomberg data. Let's
- 0:16Speaker 2: see about some stocks on the move today.
- 0:18Speaker 1: We can do that with Bloomberg's avalon per Now atline,
- 0:21Speaker 1: what are you looking at today? Yeah, we can go
- 0:22Speaker 1: ahead and start off with ARM Holdings. That's ticker ARM
- 0:25Speaker 1: gaining about seventeen percent for its biggest interday leap since
- 0:28Speaker 1: last April. That's after the semiconductor devices firm said it
- 0:31Speaker 1: will begin to sell its own chips for the first
- 0:34Speaker 1: time and another bid for AI sales. Meta has already
- 0:37Speaker 1: said that it's going to be the first major customer
- 0:39Speaker 1: and the chips will be produced by Taiwan Semiconductor Manufacturing.
- 0:42Speaker 1: Raymond James actually upgraded the stock to outperform from market
- 0:45Speaker 1: perform on the news of the business shift.
- 0:48Speaker 2: All right, sounds good. Next one on your list?
- 0:51Speaker 1: Yes, KB Home. That's ticker KBH sliding about five point
- 0:54Speaker 1: six percent for its most inter day since December. That's
- 0:57Speaker 1: after the homebuilder's second quarter forecast old estimates practically across
- 1:01Speaker 1: the board. It also reported revenue and home deliveries for
- 1:05Speaker 1: the first quarter that slightly missed expectations. True is saying
- 1:08Speaker 1: that the results were generally disappointing, it's somewhatsprising given the
- 1:11Speaker 1: growth of new orders and management also saying in the
- 1:14Speaker 1: release that concerns surrounding the conflict in the Middle East
- 1:16Speaker 1: have introduced another layer of uncertainty for consumers who were
- 1:20Speaker 1: already facing a lot of challenges across the macro sphere.
- 1:24Speaker 1: All right, one more yes, Turns Pharmaceuticals that's ticker teern,
- 1:30Speaker 1: rising about five point five percent to hit a record high.
- 1:33Speaker 1: That's after Merk agreed to buy the biotech and a
- 1:35Speaker 1: deal valued around six point seven billion dollars. Turns its
- 1:38Speaker 1: developing a treatment for a hard to treat type of
- 1:41Speaker 1: leukemia that analysts expect could eventually rival novartists. Mark has
- 1:45Speaker 1: been on the hunt for new growth drivers as it
- 1:47Speaker 1: continues to prep for its blockbuster cancer drug, key Truda,
- 1:50Speaker 1: to lose its patent in twenty twenty eight. And important
- 1:53Speaker 1: to note that Mazuho is actually calling to steal an
- 1:55Speaker 1: excellent outcome for Turns shareholders.
- 1:58Speaker 2: This stock mover's rep from Bloomberg Radio check back with
- 2:02Speaker 2: us throughout the day. For the latest roundup of companies
- 2:05Speaker 2: making news on Wall Street, and for the latest market
- 2:08Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 2:13Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 2:16Speaker 2: the Bloomberg Business app.